QSS
WX

Quantitative Systematic Strategies’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Quantitative Systematic Strategies’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17,731
Closed -$766K – 986
2015
Q3 		$766K Buy
+17,731
New +$748K 0.38% 82

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Quantitative Systematic Strategies's WX Position: Q4 2015 in Review

Quantitative Systematic Strategies sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 17,731 shares — an estimated $766K sold.

Quantitative Systematic Strategies first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $766K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Quantitative Systematic Strategies reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 17,731 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $766K.
  • Quantitative Systematic Strategies first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • Quantitative Systematic Strategies's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $766K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2015, filed 13 Jan 2016.